Medicine and Dentistry
Adult
20%
Age
13%
Association
5%
Bleeding
9%
Blood Clotting Factor Concentrate
5%
Blood Stasis
6%
Bone Density
5%
Cancer
5%
Child
7%
Comorbidity
5%
Complication
6%
Development
18%
Disease
11%
Drug Megadose
8%
Experience
9%
Family
5%
Follow up
8%
Gene Therapy
8%
Genetic Risk Factor
5%
Haemophilia
97%
Health
21%
Immunological Tolerance
12%
Life
11%
Myelodysplastic Syndrome
8%
Odds Ratio
5%
Pain
11%
Patient
100%
Patient with Hemophilia
26%
Person
19%
Post-Hoc Analysis
5%
Prophylaxis
49%
Quality of Life
21%
Substitution Therapy
7%
Surgery
10%
Systematic Review
11%
Therapeutic Procedure
71%
Therapeutics
6%
Pharmacology, Toxicology and Pharmaceutical Science
Activated Prothrombin Complex
7%
Antibodies
11%
Blood Clotting Factor 8
22%
Chemotherapy
8%
Ciclonicate
14%
Cohort Study
6%
Haemophilia A
39%
Incidence
6%
Pharmacokinetics
11%
Recombinant Blood Clotting Factor 8
9%
Replacement Therapy
12%
Von Willebrand Factor
6%
Biochemistry, Genetics and Molecular Biology
Allele
7%
Carboxyglutamic Acid
11%
Droplet Digital Polymerase Chain Reaction
8%
Epidermal Growth Factor
13%
Factor IX
23%
Factor X
8%
Gene
18%
Genetic Determinism
9%
Genetics
10%
Immune Response
5%
Inversion
9%
N-Terminus
7%
Serine Protease
6%